[ERNA] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[ERNA] Eterna Therapeutics Inc.
Announcement Date
12-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -381.17%
YoY- -375.84%
Quarter Report
ERNA's Result
ERNA's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 487 51 0 0 0 -
PBT -26,592 -5,599 -7,311 -86,055 -2,020 90.39%
Tax 12 -8 5 8 0 -
NP -26,604 -5,591 -7,316 -86,055 -2,020 90.41%
Tax Rate - - - - - -
Total Cost 27,091 5,642 7,316 86,055 2,020 91.28%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin -5,462.83 -10,962.75 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -4.92 -1.03 -2.49 -34.05 -0.97 50.02%
EPS Diluted -4.92 -1.03 -2.49 -34.05 -0.97 50.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.